| 000 | 00944 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513085136.0 | ||
| 264 | 0 | _c19960319 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-199529050-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorgan, D J | |
| 245 | 0 | 0 |
_aClinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _cNov 1995 |
||
| 300 |
_a370-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
| 650 | 0 | 4 | _aPharmacokinetics |
| 700 | 1 | _aMcLean, A J | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 29 _gno. 5 _gp. 370-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-199529050-00005 _zAvailable from publisher's website |
| 999 |
_c8581181 _d8581181 |
||